New CFO appointed at Gujarat Inject Kerala Ltd effective 10 Aug 2026

Management Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.1%Reaction day

₹11.00

prior close

₹11.44

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.2%+0.3% vs market

Pharmaceuticals peers, median of 164sector+0.1%+0.0% vs sector

On the reaction day the stock moved 0.3 pts more than Nifty Microcap 250 and in line with its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

+0.2

15m

+0.2

30m

+0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.1-0.2+0.3+0.1+0.0

Next day

+5.2+0.2+5.0-0.5+5.7

+10.4+0.4+10.0+0.1+10.3

+11.7+0.4+11.3-0.5+12.3

+20.8+0.6+20.3-1.1+21.9

+14.8+0.9+13.9-0.7+15.5

+3.6+0.9+2.8-1.2+4.8

15d

-1.6+0.9-2.6-0.6-1.1

-8.2+2.3-10.5+1.1-9.3

-15.8-1.1-14.7-3.1-12.7

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Gujarat Inject (Kerala) Ltd's board has appointed Mr. Radadiya HardikKumar AnilBhai as Chief Financial Officer and Key Managerial Personnel, effective 10 August 2026. He holds an MCA degree and brings 7 years of experience in accounting, GST, taxation, bookkeeping, statutory compliance, and financial reporting. He will also be authorised to determine materiality of events for stock exchange disclosures alongside the Managing Director and Company Secretary.

Likely market impact

Routine leadership change. New CFO brings accounting and compliance expertise. Minimal direct impact on shareholders.